Lysophosphatidylcholine

Europe PMC · from cache · sorted by publication date

1. 1
   Zexie decoction alleviates hyperlipidemia through modulation of the PPAR signaling pathway and lysophospholipid metabolism.

   Li S, Wen ZQ, Yan P. · 2026-06-15

   open access unreviewed
2. 2
   Multi-omics integration reveals convergent extracellular matrix remodelling and lipid metabolic reprogramming as central axes of adipocyte differentiation from mouse embryonic stem cells.

   Al-Sayegh M, Khalili M, Alzaabi M, Sultana M, Ali L, Ali M, El-Hadidi M. · 2026-06-02

   open access unreviewed
3. 3
   Integrative multi-omics Mendelian randomization reveals key lipid metabolism genes as therapeutic targets for diabetic nephropathy pathogenesis.

   Liu S, Xia Y, Ding L, Zhang M, Wang W, Zhou J, Liu L. · 2026-05-31

   open access unreviewed
4. 4
   Role for TREK-1 as a polymodal sensor and regulator of cell activity.

   Winkle AJ, Odayil Muralidharan A, McClenney CR, Karimpour K, Ashfaque TM, Qureshi S, Hund TJ, Nassal D. · 2026-05-19

   open access unreviewed
5. 5
   The plasma metabolome and clinical features of patients with coeliac disease in Northwest China.

   Zhang W, Wu X, Li Y, Huang Z, Hui W, Shi T, Lu W, Bai H, Wu Q, Wang M, Liu K, Xu L, Gao F, Wu J. · 2026-05-16

   open access unreviewed
6. 6
   Serum metabolic profiling analysis of Gitelman syndrome using untargeted metabolomics.

   Han J, Ma L, Luo H. · 2026-04-29

   open access unreviewed
7. 7
   Sirtuin 5-mediated desuccinylation of PRDX6 inhibits ferroptosis and alleviates sepsis-associated acute kidney injury.

   Lin W, Dong C, Jiang Q, Lou Y, Wang L, He Z. · 2026-04-10

   cited 1× open access unreviewed
8. 8
   Emerging roles of ATP citrate lyase in kidney diseases: from pathogenic driver to therapeutic target.

   Wei M, Tao M, Tan H, Jin Z, Yang Y, Xiao Z, Li G, Chen Y. · 2026-04-09

   open access unreviewed
9. 9
   Bibliometric analysis of sacubitril/valsartan in the management of chronic kidney disease (2013-2025).

   Liu P, He X, Luo X, Xie S, Li Y, Su B. · 2026-04-07

   cited 1× open access unreviewed
10. 10
    Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease.

    Li J, Guo L, Cai W, Mei J, Liu J, Liu Y. · 2026-03-20

    cited 2× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.